UnitedHealth Maintains Outlook, Braces for COVID-19 Impact
UnitedHealth Group didn’t see much of an earnings impact from the COVID-19 pandemic in the first quarter of 2020, but the effects will crystallize in future quarters. Such was the overarching message of the company’s April 15 earnings release and conference call, which focused as much on how UnitedHealth has mobilized to respond to the pandemic as it did on the firm’s financial performance.
“While it feels awkward to be talking about earnings outlook at this moment,” UnitedHealth CEO David Wichmann said during his prepared remarks, “we are maintaining our 2020 earnings per share outlook established at our investor conference,” which was $16.25 to $16.55 per share on an adjusted basis. Wichmann added that for UnitedHealth, the financial effects of the pandemic — which at press time had claimed more than 33,000 American lives — will become clearer in the months to come.
Related Posts
Meet Our Reporters
-
Lauren Flynn Kelly Executive Editor, AIS Health, and Managing Editor, Radar on Medicare Advantage
View Lauren Flynn Kelly's Profile -
Angela Maas Managing Editor, Radar on Specialty Pharmacy and Spotlight on Market Access
View Angela Maas's Profile -
Leslie Small Managing Editor, Health Plan Weekly and Radar on Drug Benefits
View Leslie Small's Profile -
Peter Johnson Reporter, Health Plan Weekly and Radar on Drug Benefits
View Peter Johnson's Profile -
Tim Casey Reporter, Health Plan Weekly and Radar on Drug Benefits
View Tim Casey's Profile -
Carina Belles Reporter, Radar on Medicare Advantage and Spotlight on Market Access
View Carina Belles's Profile -
Jinghong Chen Reporter, Health Plan Weekly and Radar on Drug Benefits
View Jinghong Chen's Profile
